Patents by Inventor Silpa Nuthalapati

Silpa Nuthalapati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX
    Publication number: 20230019186
    Abstract: The invention described herein relates to methods for treating a human subject with myelofibrosis or an MPN-related disorder, comprising administering navitoclax to the subject optionally in combination with ruxolitinib.
    Type: Application
    Filed: February 15, 2022
    Publication date: January 19, 2023
    Inventors: John Hayslip, Leanne M. Holes, Sven Mensing, Silpa Nuthalapati
  • Dosing regimens for use in treating myelofibrosis and MPN-related disorders with navitoclax
    Patent number: 11285159
    Abstract: The invention described herein relates to methods for treating a human subject with myelofibrosis or an MPN-related disorder, comprising administering navitoclax to the subject optionally in combination with ruxolitinib.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: March 29, 2022
    Assignees: AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
    Inventors: John Hayslip, Leanne M. Holes, Sven Mensing, Silpa Nuthalapati
  • DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX
    Publication number: 20210128573
    Abstract: The invention described herein relates to methods for treating a human subject with myelofibrosis or an MPN-related disorder, comprising administering navitoclax to the subject optionally in combination with ruxolitinib.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 6, 2021
    Inventors: John Hayslip, Leanne M. Holes, Sven Mensing, Silpa Nuthalapati
  • EXTENDED RELEASE FORMULATIONS OF VELIPARIB FOR THE TREATMENT OF CANCER
    Publication number: 20190029951
    Abstract: Described herein are extended release formulations of veliparib, ways to make them, and methods of treating cancer using them.
    Type: Application
    Filed: January 31, 2017
    Publication date: January 31, 2019
    Inventors: Hao Xiong, Alyssa E. Debord, Philip Komarnitsky, Silpa Nuthalapati, Sven Stodtmann